Document:

<PAGE>

                                                                     Exhibit 4.5

                                WARRANT AGREEMENT

      Agreement made as of _________, 2005 between Confluence Acquisition
Partners I, Inc., a Delaware corporation, with offices at 12444 Powerscourt
Drive, Suite 225, St. Louis, Missouri 63131, ("Company"), and Continental Stock
Transfer & Trust Company, a New York corporation, with offices at 17 Battery
Place, 8th Floor, New York, New York 10004 ("Warrant Agent").

      WHEREAS, the Company is engaged in a public offering ("Public Offering")
of Units ("Units") and, in connection therewith, has determined to issue and
deliver up to (i) 8,000,000 Warrants ("Public Warrants") to the public
investors, and (ii) 400,000 Warrants to Dawson James Securities, Inc. (the
"Representative") or its designees ("Representative's Warrants" and, together
with the Public Warrants, the "Warrants"), each of such Public Warrants
evidencing the right of the holder thereof to purchase one share of common
stock, par value $0.01 per share, of the Company's Common Stock ("Common Stock")
for $5.00, subject to adjustment as described herein; and

      WHEREAS, the Company has filed with the Securities and Exchange Commission
a Registration Statement, No. 333-_______on Form S-1 ("Registration Statement")
for the registration, under the Securities Act of 1933, as amended ("Act") of,
among other securities, the Warrants and the Common Stock issuable upon exercise
of the Warrants; and

      WHEREAS, the Company desires the Warrant Agent to act on behalf of the
Company, and the Warrant Agent is willing to so act, in connection with the
issuance, registration, transfer, exchange, redemption and exercise of the
Warrants; and

      WHEREAS, the Company desires to provide for the form and provisions of the
Warrants, the terms upon which they shall be issued and exercised, and the
respective rights, limitation of rights, and immunities of the Company, the
Warrant Agent, and the holders of the Warrants; and

      WHEREAS, all acts and things have been done and performed which are
necessary to make the Warrants, when executed on behalf of the Company and
countersigned by or on behalf of the Warrant Agent, as provided herein, the
valid, binding and legal obligations of the Company, and to authorize the
execution and delivery of this Agreement.

      NOW, THEREFORE, in consideration of the mutual agreements herein
contained, the parties hereto agree as follows:

1.    Appointment of Warrant Agent. The Company hereby appoints the Warrant
Agent to act as agent for the Company for the Warrants, and the Warrant Agent
hereby accepts such appointment and agrees to perform the same in accordance
with the terms and conditions set forth in this Agreement.

2.    Warrants.

      2.1   Form of Warrant. Each Warrant shall be issued in registered form
only, shall be in substantially the form of Exhibit A hereto, the provisions of
which are incorporated herein and shall be signed by, or bear the facsimile
signature of, the Chief Executive Officer, Chairman of

                                       1
<PAGE>

the Board or President and Treasurer, Secretary or Assistant Secretary of the
Company and shall bear a facsimile of the Company's seal. In the event the
person whose facsimile signature has been placed upon any Warrant shall have
ceased to serve in the capacity in which such person signed the Warrant before
such Warrant is issued, it may be issued with the same effect as if he or she
had not ceased to be such at the date of issuance.

      2.2   Effect of Countersignature. Unless and until countersigned by the
Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no
effect and may not be exercised by the holder thereof.

      2.3   Registration.

            2.3.1 Warrant Register. The Warrant Agent shall maintain books
("Warrant Register"), for the registration of original issuance and the
registration of transfer of the Warrants. Upon the initial issuance of the
Warrants, the Warrant Agent shall issue and register the Warrants in the names
of the respective holders thereof in such denominations and otherwise in
accordance with instructions delivered to the Warrant Agent by the Company.

            2.3.2 Registered Holder. Prior to due presentment for registration
of transfer of any Warrant, the Company and the Warrant Agent may deem and treat
the person in whose name such Warrant shall be registered upon the Warrant
Register ("registered holder"), as the absolute owner of such Warrant and of
each Warrant represented thereby (notwithstanding any notation of ownership or
other writing on the Warrant Certificate made by anyone other than the Company
or the Warrant Agent), for the purpose of any exercise thereof, and for all
other purposes, and neither the Company nor the Warrant Agent shall be affected
by any notice to the contrary.

      2.4   Detachability of Warrants. The securities comprising the Units will
not be separately transferable until 90 days after the date hereof unless the
Representative informs the Company of its decision to allow earlier separate
trading, but in no event will the Representative allow separate trading of the
securities comprising the Units until the Company files a Current Report on Form
8-K which includes an audited balance sheet reflecting the receipt by the
Company of the gross proceeds of the Public Offering including the proceeds
received by the Company from the exercise of the Underwriter's over-allotment
option, if the over-allotment option is exercised prior to the filing of the
Form 8-K.

      2.5   Warrants and Representative's Warrants. The Representative's
Warrants shall have the same terms and be in the same form as the Public
Warrants except with respect to the Warrant Price as set forth below in Section
3.1.

3.    Terms and Exercise of Warrants.

      3.1   Warrant Price. Each Public Warrant shall, when countersigned by the
Warrant Agent, entitle the registered holder thereof, subject to the provisions
of such Public Warrant and of this Warrant Agreement, to purchase from the
Company the number of shares of Common Stock stated therein, at the price of
$5.00 per whole share, subject to the adjustments provided in Section 4 hereof
and in the last sentence of this Section 3.1. Each Representative's Warrant
shall, when countersigned by the Warrant Agent, entitle the registered holder
thereof, subject to the

                                       2
<PAGE>

provisions of such Representative's Warrant and of this Warrant Agreement, to
purchase from the Company the number of shares of Common Stock stated therein,
at the price of $6.25 per whole share, subject to the adjustments provided in
Section 4 hereof. The term "Warrant Price" as used in this Warrant Agreement
refers to the price per share at which Common Stock may be purchased at the time
a Warrant is exercised. The Company in its sole discretion may lower the Warrant
Price at any time prior to the Expiration Date.

      3.2   Duration of Warrants. A Warrant may be exercised only during the
period ("Exercise Period") commencing on the later of the consummation by the
Company of a merger, capital stock exchange, asset acquisition or other similar
business combination ("Business Combination") (as described more fully in the
Company's Registration Statement) or ______, 2006, and terminating at 5:00 p.m.,
New York City time on the earlier to occur of (i) ________, 2010 or (ii) the
date fixed for redemption of the Warrants as provided in Section 6 of this
Agreement ("Expiration Date"). Except with respect to the right to receive the
Redemption Price (as set forth in Section 6 hereunder), each Warrant not
exercised on or before the Expiration Date shall become void, and all rights
thereunder and all rights in respect thereof under this Agreement shall cease at
the close of business on the Expiration Date. The Company in its sole discretion
may extend the duration of the Warrants by delaying the Expiration Date.

      3.3   Exercise of Warrants.

            3.3.1 Payment. Subject to the provisions of the Warrant and this
Warrant Agreement, a Warrant, when countersigned by the Warrant Agent, may be
exercised by the registered holder thereof by surrendering it, at the office of
the Warrant Agent, or at the office of its successor as Warrant Agent, in the
Borough of Manhattan, City and State of New York, with the subscription form, as
set forth in the Warrant, duly executed, and by paying in full, in lawful money
of the United States, in good certified check or good bank draft payable to the
order of the Company (or as otherwise agreed to by the Company), the Warrant
Price for each full share of Common Stock as to which the Warrant is exercised
and any and all applicable taxes due in connection with the exercise of the
Warrant, the exchange of the Warrant for the Common Stock, and the issuance of
the Common Stock.

            3.3.2 Issuance of Certificates. As soon as practicable after the
exercise of any Warrant and the clearance of the funds in payment of the Warrant
Price, the Company shall issue to the registered holder of such Warrant a
certificate or certificates for the number of full shares of Common Stock to
which he is entitled, registered in such name or names as may be directed by
him, her or it, and if such Warrant shall not have been exercised in full, a new
countersigned Warrant for the number of shares as to which such Warrant shall
not have been exercised. Notwithstanding the foregoing, the Company shall not be
obligated to deliver any securities pursuant to the exercise of a Warrant unless
a registration statement under the Act with respect to the Common Stock is
effective. Warrants may not be exercised by, or securities issued to, any
registered holder in any state in which such exercise would be unlawful.

            3.3.3 Valid Issuance. All shares of Common Stock issued upon the
proper exercise of a Warrant in conformity with this Agreement shall be validly
issued, fully paid and nonassessable.

                                       3
<PAGE>

            3.3.4 Date of Issuance. Each person in whose name any such
certificate for shares of Common Stock is issued shall for all purposes be
deemed to have become the holder of record of such shares on the date on which
the Warrant was surrendered and payment of the Warrant Price was made,
irrespective of the date of delivery of such certificate, except that, if the
date of such surrender and payment is a date when the stock transfer books of
the Company are closed, such person shall be deemed to have become the holder of
such shares at the close of business on the next succeeding date on which the
stock transfer books are open.

            3.3.5 Warrant Solicitation and Warrant Solicitation Fee.

                  a.    The Company has engaged the Representative, on a
non-exclusive basis, as its agent for the solicitation of the exercise of the
Warrants. The Company, at its cost, will (i) assist the Representative with
respect to such solicitation, if requested by the Representative, and (ii)
provide the Representative, and direct the Company's transfer agent and the
Warrant Agent to deliver to the Representative, lists of the record and, to the
extent known, beneficial owners of the Company's Warrants. The Company hereby
instructs the Warrant Agent to cooperate with the Representative in every
respect in connection with the Representative's solicitation activities,
including, but not limited to, providing to the Representative, at the Company's
cost, a list of record holders of the Warrants and circulating a prospectus or
offering circular disclosing the compensation arrangements referenced in Section
3.3.5(b) below to holders of the Warrants at the time of exercise of the
Warrants. In addition to the conditions set forth in Section 3.3.5(b), the
Representative shall accept payment of the warrant solicitation fee provided in
Section 3.3.5(b) only if it has provided bona fide services to the Company in
connection with the exercise of the Warrants and only to the extent that an
investor who exercises his Warrants specifically designates, in writing, that
the Representative solicited his exercise. In addition to soliciting, either
orally or in writing, the exercise of Warrants by a Warrant holder, such
services may also include disseminating information, either orally or in
writing, to Warrant holders about the Company or the market for the Company's
securities, or assisting in the processing of the exercise of Warrants.

                  b.    In each instance in which a Warrant is exercised, the
Warrant Agent shall promptly give written notice of such exercise to the Company
and the Representative ("Warrant Agent's Exercise Notice"). If, upon the
exercise of any Warrant more than one year from the effective date of the
Registration Statement, (i) the market price of the Company's Common Stock is
greater than the Warrant Price, (ii) disclosure of compensation arrangements
between the Company and the Representative with respect to the solicitation of
the exercise of the Warrants was made both at the time of the Public Offering
and at the time of exercise (by delivery of the Prospectus or as otherwise
required by applicable law, rule or regulation), (iii) the holder of the Warrant
confirms in writing that the exercise of the Warrant was solicited by the
Representative, (iv) the Warrant was not held in a discretionary account, and
(v) the solicitation of the exercise of the Warrant was not in violation of
Regulation M (as such rule or any successor rule may be in effect as of such
time of exercise) promulgated under the Securities Exchange Act of 1934, as
amended, then the Warrant Agent, simultaneously with the distribution of the
Common Stock underlying the Warrants so exercised in accordance with the
instructions from the Company following receipt of the proceeds to the Company
received upon exercise of such Warrant(s), shall, on behalf of the Company, pay
a fee of 5% of the Warrant Price to the Representative, provided that the
Representative delivers to the Warrant Agent within ten (10)

                                       4
<PAGE>

business days from the date on which the Representative has received the Warrant
Agent's Exercise Notice, a certificate that the conditions set forth the
preceding clauses (iii), (iv) and (v) have been satisfied. Notwithstanding the
foregoing, no fee will be paid to the Representative with respect to the
exercise by the Underwriters or their affiliates or the Company's officers or
directors of Warrants purchased by it or them upon exercise of the
Representative's Warrants and still held by any of the Underwriters or them for
its or their own account. The Representative and the Company may at any time
during business hours, examine the records of the Warrant Agent, including its
ledger of original Warrant certificates returned to the Warrant Agent upon
exercise of Warrants.

                  c.    The provisions of this Section 3.3.5. may not be
modified, amended or deleted without the prior written consent of the
Representative.

4.    Adjustments.

      4.1   Stock Dividends - Split-Ups. If after the date hereof, and subject
to the provisions of Section 4.6 below, the number of outstanding shares of
Common Stock is increased by a stock dividend payable in shares of Common Stock,
or by a split-up of shares of Common Stock, or other similar event, then, on the
effective date of such stock dividend, split-up or similar event, the number of
shares of Common Stock issuable on exercise of each Warrant shall be increased
in proportion to such increase in outstanding shares of Common Stock.

      4.2   Aggregation of Shares. If after the date hereof, and subject to the
provisions of Section 4.6, the number of outstanding shares of Common Stock is
decreased by a consolidation, combination, reverse stock split or
reclassification of shares of Common Stock or other similar event, then, on the
effective date of such consolidation, combination, reverse stock split,
reclassification or similar event, the number of shares of Common Stock issuable
on exercise of each Warrant shall be decreased in proportion to such decrease in
outstanding shares of Common Stock.

      4.3   Adjustments in Exercise Price. Whenever the number of shares of
Common Stock purchasable upon the exercise of the Warrants is adjusted, as
provided in Section 4.1 and 4.2 above, the Warrant Price shall be adjusted (to
the nearest cent) by multiplying such Warrant Price immediately prior to such
adjustment by a fraction (x) the numerator of which shall be the number of
shares of Common Stock purchasable upon the exercise of the Warrants immediately
prior to such adjustment, and (y) the denominator of which shall be the number
of shares of Common Stock so purchasable immediately thereafter.

      4.4   Replacement of Securities upon Reorganization, etc. In case of any
reclassification or reorganization of the outstanding shares of Common Stock
(other than a change covered by Section 4.1 or 4.2 hereof or that solely affects
the par value of such shares of Common Stock), or in the case of any merger or
consolidation of the Company with or into another corporation (other than a
consolidation or merger in which the Company is the continuing corporation and
that does not result in any reclassification or reorganization of the
outstanding shares of Common Stock), or in the case of any sale or conveyance to
another corporation or entity of the assets or other property of the Company as
an entirety or substantially as an entirety in connection with which the Company
is dissolved, the Warrant

                                       5
<PAGE>

holders shall thereafter have the right to purchase and receive, upon the basis
and upon the terms and conditions specified in the Warrants and in lieu of the
shares of Common Stock of the Company immediately theretofore purchasable and
receivable upon the exercise of the rights represented thereby, the kind and
amount of shares of stock or other securities or property (including cash)
receivable upon such reclassification, reorganization, merger or consolidation,
or upon a dissolution following any such sale or transfer, that the Warrant
holder would have received if such Warrant holder had exercised his, her or its
Warrant(s) immediately prior to such event; and if any reclassification also
results in a change in shares of Common Stock covered by Section 4.1 or 4.2,
then such adjustment shall be made pursuant to Sections 4.1, 4.2, 4.3 and this
Section 4.4. The provisions of this Section 4.4 shall similarly apply to
successive reclassifications, reorganizations, mergers or consolidations, sales
or other transfers.

      4.5   Notices of Changes in Warrant. Upon every adjustment of the Warrant
Price or the number of shares issuable upon exercise of a Warrant, the Company
shall give written notice thereof to the Warrant Agent, which notice shall state
the Warrant Price resulting from such adjustment and the increase or decrease,
if any, in the number of shares purchasable at such price upon the exercise of a
Warrant, setting forth in reasonable detail the method of calculation and the
facts upon which such calculation is based. Upon the occurrence of any event
specified in Sections 4.1, 4.2, 4.3 or 4.4, then, in any such event, the Company
shall give written notice to the Warrant holder, at the last address set forth
for such holder in the warrant register, of the record date or the effective
date of the event. Failure to give such notice, or any defect therein, shall not
affect the legality or validity of such event.

      4.6   No Fractional Shares. Notwithstanding any provision contained in
this Warrant Agreement to the contrary, the Company shall not issue fractional
shares upon exercise of Warrants. If, by reason of any adjustment made pursuant
to this Section 4, the holder of any Warrant would be entitled, upon the
exercise of such Warrant, to receive a fractional interest in a share, the
Company shall, upon such exercise, round up to the nearest whole number the
number of the shares of Common Stock to be issued to the Warrant holder.

      4.7   Form of Warrant. The form of Warrant need not be changed because of
any adjustment pursuant to this Section 4, and Warrants issued after such
adjustment may state the same Warrant Price and the same number of shares as is
stated in the Warrants initially issued pursuant to this Agreement. However, the
Company may at any time in its sole discretion make any change in the form of
Warrant that the Company may deem appropriate and that does not affect the
substance thereof, and any Warrant thereafter issued or countersigned, whether
in exchange or substitution for an outstanding Warrant or otherwise, may be in
the form as so changed.

5.    Transfer and Exchange of Warrants.

      5.1   Registration of Transfer. The Warrant Agent shall register the
transfer, from time to time, of any outstanding Warrant upon the Warrant
Register, upon surrender of such Warrant for transfer, properly endorsed with
signatures properly guaranteed and accompanied by appropriate instructions for
transfer. Upon any such transfer, a new Warrant representing an equal aggregate
number of Warrants shall be issued and the old Warrant shall be cancelled by the

                                       6
<PAGE>

Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent
to the Company from time to time upon request.

      5.2   Procedure for Surrender of Warrants. Warrants may be surrendered to
the Warrant Agent, together with a written request for exchange or transfer, and
thereupon the Warrant Agent shall issue in exchange therefor one or more new
Warrants as requested by the registered holder of the Warrants so surrendered,
representing an equal aggregate number of Warrants; provided, however, that in
the event that a Warrant surrendered for transfer bears a restrictive legend,
the Warrant Agent shall not cancel such Warrant and issue new Warrants in
exchange therefor until the Warrant Agent has received an opinion of counsel for
the Company stating that such transfer may be made and indicating whether the
new Warrants must also bear a restrictive legend.

      5.3   Fractional Warrants. The Warrant Agent shall not be required to
effect any registration of transfer or exchange which will result in the
issuance of a warrant certificate for a fraction of a warrant.

      5.4   Service Charges. No service charge shall be made for any exchange or
registration of transfer of Warrants.

      5.5   Warrant Execution and Countersignature. The Warrant Agent is hereby
authorized to countersign and to deliver, in accordance with the terms of this
Agreement, the Warrants required to be issued pursuant to the provisions of this
Section 5, and the Company, whenever required by the Warrant Agent, will supply
the Warrant Agent with Warrants duly executed on behalf of the Company for such
purpose.

6.    Redemption.

      6.1   Redemption. Subject to Section 6.4 hereof, with the prior consent of
the Representative, not less than all of the outstanding Warrants may be
redeemed, at the option of the Company, at any time after they become
exercisable and prior to their expiration, at the office of the Warrant Agent,
upon the notice referred to in Section 6.2., at the price of $.01 per Warrant
("Redemption Price"), provided that the last sales price of the Common Stock has
been at least $8.50 per share, on each of twenty (20) trading days within any
thirty (30) trading day period ending on the third business day prior to the
date on which notice of redemption is given. The provisions of this Section 6.1
may not be modified, amended or deleted without the prior written consent of the
Representative.

      6.2   Date Fixed for, and Notice of, Redemption. In the event the Company
shall elect to redeem all of the Warrants, the Company shall fix a date for the
redemption. Notice of redemption shall be mailed by first class mail, postage
prepaid, by the Company not less than 30 days prior to the date fixed for
redemption to the registered holders of the Warrants to be redeemed at their
last addresses as they shall appear on the registration books. Any notice mailed
in the manner herein provided shall be conclusively presumed to have been duly
given whether or not the registered holder received such notice.

      6.3   Exercise After Notice of Redemption. The Warrants may be exercised
in accordance with Section 3 of this Agreement at any time after notice of
redemption shall have

                                       7
<PAGE>

been given by the Company pursuant to Section 6.2. hereof and prior to the time
and date fixed for redemption. On and after the redemption date, the record
holder of the Warrants shall have no further rights except to receive, upon
surrender of the Warrants, the Redemption Price.

      6.4   Exclusion of Certain Warrants. The Company understands that the
redemption rights provided for by this Section 6 apply only to outstanding
Warrants. To the extent a person holds rights to purchase Warrants, such
purchase rights shall not be extinguished by redemption. However, once such
purchase rights are exercised, the Company may redeem the Warrants issued upon
such exercise provided that the criteria for redemption are met. The provisions
of this Section 6.4 may not be modified, amended or deleted without the prior
written consent of the Representative.

7.    Other Provisions Relating to Rights of Holders of Warrants.

      7.1   No Rights as Stockholder. A Warrant does not entitle the registered
holder thereof to any of the rights of a stockholder of the Company, including,
without limitation, the right to receive dividends, or other distributions,
exercise any preemptive rights to vote or to consent or to receive notice as
stockholders in respect of the meetings of stockholders or the election of
directors of the Company or any other matter.

      7.2   Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is
lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on
such terms as to indemnity or otherwise as they may in their discretion impose
(which shall, in the case of a mutilated Warrant, include the surrender
thereof), issue a new Warrant of like denomination, tenor, and date as the
Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall
constitute a substitute contractual obligation of the Company, whether or not
the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time
enforceable by anyone.

      7.3   Reservation of Common Stock. The Company shall at all times reserve
and keep available a number of its authorized but unissued shares of Common
Stock that will be sufficient to permit the exercise in full of all outstanding
Warrants issued pursuant to this Agreement.

      7.4   Registration of Common Stock. The Company agrees that prior to the
commencement of the Exercise Period, it shall file with the Securities and
Exchange Commission a post-effective amendment to the Registration Statement, or
a new registration statement, for the registration, under the Act, of, and it
shall take such action as is necessary to qualify for sale, in those states in
which the Warrants were initially offered by the Company, the Common Stock
issuable upon exercise of the Warrants. In either case, the Company will use its
best efforts to cause the same to become effective and to maintain the
effectiveness of such registration statement until the expiration of the
Warrants in accordance with the provisions of this Agreement. The provisions of
this Section 7.4 may not be modified, amended or deleted without the prior
written consent of the Representative.

8.    Concerning the Warrant Agent and Other Matters.

      8.1   Payment of Taxes. The Company will from time to time promptly pay
all taxes and charges that may be imposed upon the Company or the Warrant Agent
in respect of the issuance or delivery of shares of Common Stock upon the
exercise of Warrants, but the

                                       8
<PAGE>

Company shall not be obligated to pay any transfer taxes in respect of the
Warrants or such shares.

      8.2   Resignation, Consolidation, or Merger of Warrant Agent.

            8.2.1 Appointment of Successor Warrant Agent. The Warrant Agent, or
any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days'
notice in writing to the Company. If the office of the Warrant Agent becomes
vacant by resignation or incapacity to act or otherwise, the Company shall
appoint in writing a successor Warrant Agent in place of the Warrant Agent. If
the Company shall fail to make such appointment within a period of thirty (30)
days after it has been notified in writing of such resignation or incapacity by
the Warrant Agent or by the holder of the Warrant (who shall, with such notice,
submit his Warrant for inspection by the Company), then the holder of any
Warrant may apply to the Supreme Court of the State of New York for the County
of New York for the appointment of a successor Warrant Agent at the Company's
cost. Any successor Warrant Agent, whether appointed by the Company or by such
court, shall be a corporation organized and existing under the laws of the State
of New York, in good standing and having its principal office in the Borough of
Manhattan, City and State of New York, and authorized under such laws to
exercise corporate trust powers and subject to supervision or examination by
federal or state authority. After appointment, any successor Warrant Agent shall
be vested with all the authority, powers, rights, immunities, duties, and
obligations of its predecessor Warrant Agent with like effect as if originally
named as Warrant Agent hereunder, without any further act or deed; but if for
any reason it becomes necessary or appropriate, the predecessor Warrant Agent
shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and
rights of such predecessor Warrant Agent hereunder; and upon request of any
successor Warrant Agent the Company shall make, execute, acknowledge, and
deliver any and all instruments in writing for more fully and effectually
vesting in and confirming to such successor Warrant Agent all such authority,
powers, rights, immunities, duties, and obligations.

            8.2.2 Notice of Successor Warrant Agent. In the event a successor
Warrant Agent shall be appointed, the Company shall give notice thereof to the
predecessor Warrant Agent and the transfer agent for the Common Stock not later
than the effective date of any such appointment.

            8.2.3 Merger or Consolidation of Warrant Agent. Any corporation into
which the Warrant Agent may be merged or with which it may be consolidated or
any corporation resulting from any merger or consolidation to which the Warrant
Agent shall be a party shall be the successor Warrant Agent under this Agreement
without any further act.

      8.3   Fees and Expenses of Warrant Agent.

            8.3.1 Remuneration. The Company agrees to pay the Warrant Agent
reasonable remuneration for its services as such Warrant Agent hereunder and
will reimburse the Warrant Agent upon demand for all expenditures that the
Warrant Agent may reasonably incur in the execution of its duties hereunder.

                                       9
<PAGE>

            8.3.2 Further Assurances. The Company agrees to perform, execute,
acknowledge, and deliver or cause to be performed, executed, acknowledged, and
delivered all such further and other acts, instruments, and assurances as may
reasonably be required by the Warrant Agent for the carrying out or performing
of the provisions of this Agreement.

      8.4   Liability of Warrant Agent.

            8.4.1 Reliance on Company Statement. Whenever in the performance of
its duties under this Warrant Agreement, the Warrant Agent shall deem it
necessary or desirable that any fact or matter be proved or established by the
Company prior to taking or suffering any action hereunder, such fact or matter
(unless other evidence in respect thereof be herein specifically prescribed) may
be deemed to be conclusively proved and established by a statement signed by the
Chief Executive Officer, President or Chairman of the Board of the Company and
delivered to the Warrant Agent. The Warrant Agent may rely upon such statement
for any action taken or suffered in good faith by it pursuant to the provisions
of this Agreement.

            8.4.2 Indemnity. The Warrant Agent shall be liable hereunder only
for its own negligence, willful misconduct or bad faith. The Company agrees to
indemnify the Warrant Agent and save it harmless against any and all
liabilities, including judgments, costs and reasonable counsel fees, for
anything done or omitted by the Warrant Agent in the execution of this Agreement
except as a result of the Warrant Agent's negligence, willful misconduct, or bad
faith.

            8.4.3 Exclusions. The Warrant Agent shall have no responsibility
with respect to the validity of this Agreement or with respect to the validity
or execution of any Warrant (except its countersignature thereof); nor shall it
be responsible for any breach by the Company of any covenant or condition
contained in this Agreement or in any Warrant; nor shall it be responsible to
make any adjustments required under the provisions of Section 4 hereof or
responsible for the manner, method, or amount of any such adjustment or the
ascertaining of the existence of facts that would require any such adjustment;
nor shall it by any act hereunder be deemed to make any representation or
warranty as to the authorization or reservation of any shares of Common Stock to
be issued pursuant to this Agreement or any Warrant or as to whether any shares
of Common Stock will when issued be valid and fully paid and nonassessable.

      8.5   Acceptance of Agency. The Warrant Agent hereby accepts the agency
established by this Agreement and agrees to perform the same upon the terms and
conditions herein set forth and among other things, shall account promptly to
the Company with respect to Warrants exercised and concurrently account for, and
pay to the Company, all moneys received by the Warrant Agent for the purchase of
shares of the Company's Common Stock (less any warrant solicitation fee due to
the Representative pursuant to Section 3.3.5 herein) through the exercise of
Warrants.

                                       10
<PAGE>

9.    Miscellaneous Provisions.

      9.1   Successors. All the covenants and provisions of this Agreement by or
for the benefit of the Company or the Warrant Agent shall bind and inure to the
benefit of their respective successors and assigns.

      9.2   Notices. Any notice, statement or demand authorized by this Warrant
Agreement to be given or made by the Warrant Agent or by the holder of any
Warrant to or on the Company shall be sufficiently given when so delivered if by
hand or overnight delivery or if sent by certified mail or private courier
service within five days after deposit of such notice, postage prepaid,
addressed (until another address is filed in writing by the Company with the
Warrant Agent), as follows:

      Confluence Acquisition Partners I, Inc.
      12444 Powerscourt Drive
      Suite 225
      St. Louis, Missouri 63131
      Attn: Chief Executive Officer

Any notice, statement or demand authorized by this Agreement to be given or made
by the holder of any Warrant or by the Company to or on the Warrant Agent shall
be sufficiently given when so delivered if by hand or overnight delivery or if
sent by certified mail or private courier service within five days after deposit
of such notice, postage prepaid, addressed (until another address is filed in
writing by the Warrant Agent with the Company), as follows:

      Continental Stock Transfer & Trust Company
      17 Battery Place
      8th Floor
      New York, New York 10004
      Attn: Compliance Department

with a copy in each case to:

      Dilworth Paxson LLP
      1818 N. Street, N.W.
      Suite 400
      Washington, DC 20036
      Attn: Kathleen L. Cerveny, Esq.

and

      Dawson James Securities, Inc.
      925 South Federal Highway
      6th Floor
      Boca Raton, FL  33432
      Attn: Robert D. Keyser

and

                                       11
<PAGE>

      Blank Rome, LLP
      1200 N. Federal Highway, Suite 417
      Boca Raton, FL  33432
      Attn: Bruce C. Rosetto, Esq.

      9.3   Applicable law. The validity, interpretation, and performance of
this Agreement and of the Warrants shall be governed in all respects by the laws
of the State of New York, without giving effect to conflict of laws. The Company
hereby agrees that any action, proceeding or claim against it arising out of or
relating in any way to this Agreement shall be brought and enforced in the
courts of the State of New York or the United States District Court for the
Southern District of New York, and irrevocably submits to such jurisdiction,
which jurisdiction shall be exclusive. The Company hereby waives any objection
to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any such process or summons to be served upon the Company may be served
by transmitting a copy thereof by registered or certified mail, return receipt
requested, postage prepaid, addressed to it at the address set forth in Section
9.2 hereof. Such mailing shall be deemed personal service and shall be legal and
binding upon the Company in any action, proceeding or claim.

      9.4   Persons Having Rights under this Agreement. Nothing in this
Agreement expressed and nothing that may be implied from any of the provisions
hereof is intended, or shall be construed, to confer upon, or give to, any
person or corporation other than the parties hereto and the registered holders
of the Warrants and, for the purposes of Sections 3.3.5, 6.1, 6.4, 7.4 and 9.2
hereof, the Representative, any right, remedy, or claim under or by reason of
this Warrant Agreement or of any covenant, condition, stipulation, promise, or
agreement hereof. The Representative shall be deemed to be a third-party
beneficiary of this Agreement with respect to Sections 3.3.5, 6.1, 6.4, 7.4 and
9.2 hereof. All covenants, conditions, stipulations, promises, and agreements
contained in this Warrant Agreement shall be for the sole and exclusive benefit
of the parties hereto (and the Representative with respect to the Sections
3.3.5, 6.1, 6.4, 7.4 and 9.2 hereof) and their successors and assigns and of the
registered holders of the Warrants.

      9.5   Examination of the Warrant Agreement. A copy of this Agreement shall
be available at all reasonable times at the office of the Warrant Agent in the
Borough of Manhattan, City and State of New York, for inspection by the
registered holder of any Warrant. The Warrant Agent may require any such holder
to submit his Warrant for inspection by it.

      9.6   Counterparts. This Agreement may be executed in any number of
counterparts and each of such counterparts shall for all purposes be deemed to
be an original, and all such counterparts shall together constitute but one and
the same instrument.

      9.7   Effect of Headings. The Section headings herein are for convenience
only and are not part of this Warrant Agreement and shall not affect the
interpretation thereof.

                                       12
<PAGE>

      IN WITNESS WHEREOF, this Agreement has been duly executed by the parties
hereto as of the day and year first above written.

Attest:                                  CONFLUENCE ACQUISITION PARTNERS I, INC.

___________________________________      By:   ______________________________

                                         Name:     John J. Klobnak

                                         Title:    President

Attest:                                  CONTINENTAL STOCK TRANSFER
                                         & TRUST COMPANY

____________________________________     By:   ______________________________

                                         Name:     Steven Nelson

                                         Title:    President

                                       13<PAGE>

                                                                    Exhibit 10.1
                                     (form for executive officers and directors)

                                ____________ 2005

Confluence Acquisition Partners I, Inc.
12444 Powerscourt Drive
Suite 225
St. Louis, Missouri 63131

Dawson James Securities, Inc.
925 South Federal Highway, 6th Floor
Boca Raton, FL  33432

Re: Initial Public Offering

Gentlemen:

      The undersigned stockholder, officer and director of Confluence
Acquisition Partners I, Inc. (the "Company"), in consideration of Dawson James
Securities, Inc. (the "Underwriter") entering into a letter of intent (the
"Letter of Intent") to underwrite an initial public offering of the securities
of the Company ("IPO") and embarking on the IPO process, hereby agrees as
follows (certain capitalized terms used herein are defined in paragraph 13
hereof):

      1. If the Company solicits approval of its stockholders of a Business
Combination, the undersigned will vote all Insider Shares owned by him in
accordance with the majority of the votes cast by the holders of the IPO Shares.

      2. In the event that the Company fails to consummate a Business
Combination within 18 months from the effective date (the "Effective Date") of
the registration statement (the "Registration Statement") relating to the IPO
(or 24 months under the circumstances described in the prospectus relating to
the IPO), the undersigned will (i) cause the Trust Fund (as defined in the
Registration Statement") to be liquidated and distributed to the holders of IPO
Shares and (ii) take all reasonable actions within his power to cause the
Company to liquidate as soon as reasonably practicable. The undersigned waives
any and all right, title, interest or claim of any kind in or to any
distribution of the Trust Fund and any remaining net assets of the Company he
may have to receive any distribution of cash, property or other assets as a
result of such liquidation with respect to his Insider Shares ("Claim") and
hereby waives any Claim the undersigned may have in the future as a result of,
or arising out of, any contracts or agreements with the Company and will not
seek recourse against the Trust Fund for any reason whatsoever. The undersigned
agrees to indemnify and hold harmless the Company against any and all loss,
liability, claims, damage and expense whatsoever (including, but not limited to,
any and all legal or other expenses reasonably incurred in investigating,
preparing or defending against any litigation, whether pending or threatened, or
any claim whatsoever) to which the Company may become subject as a

<PAGE>

result of any claim by any vendor or other person who is owed money by the
Company for services rendered or products sold but only to the extent necessary
to ensure that such loss, liability, claim, damage or expense does not reduce
the amount in the Trust Fund.

      3. In order to minimize potential conflicts of interest which may arise
from multiple affiliations, the undersigned agrees to present to the Company for
its consideration, prior to presentation to any other person or entity, any
suitable opportunity to acquire an operating business in the healthcare
industry, until the earlier of the consummation by the Company of a Business
Combination, the liquidation of the Company or until such time as the
undersigned ceases to be an officer or director of the Company, subject to any
pre-existing fiduciary obligations the undersigned might have.

      4. The undersigned acknowledges and agrees that the Company will not
consummate any Business Combination that involves a company which is affiliated
with any of the Insiders unless the Company obtains an opinion from an
independent investment banking firm reasonably acceptable to the Underwriter
that the Business Combination is fair to the Company's stockholders from a
financial perspective.

      5. Neither the undersigned, any member of the family of the undersigned,
nor any affiliate ("Affiliate") of the undersigned will be entitled to receive
and will not accept any compensation for services rendered to the Company prior
to the consummation of the Business Combination; provided that, commencing on
the Effective Date, Confluence Acquisition, LLC, a limited liability company
("Related Party"), shall be allowed to charge the Company an allocable share of
Related Party's overhead, up to $7,500 per month, to compensate it for the
Company's use of Related Party's offices, utilities and personnel. Related Party
and the undersigned shall also be entitled to reimbursement from the Company for
their out-of-pocket expenses incurred in connection with seeking and
consummating a Business Combination.

      6. Neither the undersigned, any member of the family of the undersigned,
nor any Affiliate of the undersigned will be entitled to receive or accept a
finder's fee or any other compensation in the event the undersigned, any member
of the family of the undersigned or any Affiliate of the undersigned originates
a Business Combination.

      7. The undersigned will escrow his Insider Shares for the three year
period commencing on the Effective Date subject to the terms of a Stock Escrow
Agreement which the Company will enter into with the undersigned and Continental
Stock Transfer & Trust Company as escrow agent.

      8. The undersigned agrees that, during the period terminating on the third
anniversary of the Effective Date, he will not become involved (whether as
owner, manager, operator, creditor, partner, shareholder, joint venturer,
member, employee, officer, director, consultant or otherwise) with any
Acquisition Fund (as defined in Section 13(i) below), unless such Acquisition
Fund engages the Underwriter to be the managing underwriter of the initial
public offering of the Acquisition Fund's securities.

                                       2
<PAGE>

      The undersigned hereby agrees and acknowledges that (i) the Underwriter
would be irreparably injured in the event of a breach by the undersigned of any
of his obligations under this paragraph 8, (ii) monetary damages would not be an
adequate remedy for any such breach, and (iii) the Underwriter shall be entitled
to injunctive relief, in addition to any other remedy they may have, in the
event of such breach.

      9. The undersigned agrees to serve as the _______________________ and
Director of the Company until the earlier of the consummation by the Company of
a Business Combination or the liquidation of the Company. The undersigned's
biographical information furnished to the Company and the Underwriter included
in the S-1 Registration Statement is true and accurate in all respects, does not
omit any material information with respect to the undersigned's background and
contains all of the information required to be disclosed pursuant to Section 401
of Regulation S-K, promulgated under the Securities Act of 1933, as amended. The
undersigned's Questionnaire furnished to the Company and the Underwriter is true
and accurate in all respects. The undersigned represents and warrants that:

            (a) he is not subject to or a respondent in any legal action for,
any injunction, cease-and-desist order or order or stipulation to desist or
refrain from any act or practice relating to the offering of securities in any
jurisdiction;

            (b) he has never been convicted of or pleaded guilty to any crime
(i) involving any fraud or (ii) relating to any financial transaction or
handling of funds of another person, or (iii) pertaining to any dealings in any
securities and he is not currently a defendant in any such criminal proceeding;
and

            (c) he has never been suspended or expelled from membership in any
securities or commodities exchange or association or had a securities or
commodities license or registration denied, suspended or revoked.

      10. The undersigned has full right and power, without violating any
agreement by which he is bound, to enter into this letter agreement and to serve
as an officer and/or director of the Company.

      11. The undersigned authorizes any employer, financial institution, or
consumer credit reporting agency to release to the Underwriter and its legal
representatives or agents (including any investigative search firm retained by
the Underwriter) any information they may have about my background and finances
(the "Information"). Neither the Underwriter nor its agents shall be violating
the undersigned's right of privacy in any manner in requesting and obtaining the
Information and the undersigned hereby releases them from liability for any
damage whatsoever in that connection.

      12. This letter agreement shall be governed by and construed and enforced
in accordance with the laws of the State of Delaware, without giving effect to
conflicts of laws principles that would result in the application of the
substantive laws of another jurisdiction.

                                       3
<PAGE>

      13. As used herein,

                  (i) "Acquisition Fund" shall mean any company formed with the
intent to offer securities to the public and use the proceeds to consummate one
or more Business Combinations which are unspecified at the time of the
securities offering.

                  (ii) "Business Combination" shall mean an acquisition by
merger, capital stock exchange, asset or stock acquisition, reorganization or
otherwise, of an operating business selected by the Company;

                  (iii) "Insiders" shall mean all officers, directors and
stockholders of the Company immediately prior to the IPO;

                  (iv) "Insider Shares" shall mean all of the shares of Common
Stock of the Company owned by an Insider prior to the IPO;

                  (v) "IPO Shares" shall mean the shares of Common Stock issued
in the Company's IPO; and

                  (vi) "Questionnaire" means that Questionnaire for Officers and
Directors executed by the undersigned together with any supplement or amendment
thereto.

                                                  _________________________

                                       4
<PAGE>

                                              (form for individual stockholders)

                                ____________ 2005

Confluence Acquisition Partners I, Inc.
12444 Powerscourt Drive
Suite 225
St. Louis, Missouri 63131

Dawson James Securities, Inc.
925 South Federal Highway, 6th Floor
Boca Raton, FL  33432

Re: Initial Public Offering

Gentlemen:

      The undersigned stockholder of Confluence Acquisition Partners I, Inc.
(the "Company"), in consideration of Dawson James Securities, Inc. (the
"Underwriter") entering into a letter of intent (the "Letter of Intent") to
underwrite an initial public offering of the securities of the Company ("IPO")
and embarking on the IPO process, hereby agrees as follows (certain capitalized
terms used herein are defined in paragraph 13 hereof):

      1. If the Company solicits approval of its stockholders of a Business
Combination, the undersigned will vote all Insider Shares owned by him in
accordance with the majority of the votes cast by the holders of the IPO Shares.

      2. In the event that the Company fails to consummate a Business
Combination within 18 months from the effective date (the "Effective Date") of
the registration statement (the "Registration Statement") relating to the IPO
(or 24 months under the circumstances described in the prospectus relating to
the IPO), the undersigned will (i) cause the Trust Fund (as defined in the
Registration Statement") to be liquidated and distributed to the holders of IPO
Shares and (ii) take all reasonable actions within his power to cause the
Company to liquidate as soon as reasonably practicable. The undersigned waives
any and all right, title, interest or claim of any kind in or to any
distribution of the Trust Fund and any remaining net assets of the Company he
may have to receive any distribution of cash, property or other assets as a
result of such liquidation with respect to his Insider Shares ("Claim") and
hereby waives any Claim the undersigned may have in the future as a result of,
or arising out of, any contracts or agreements with the Company and will not
seek recourse against the Trust Fund for any reason whatsoever.

      3. In order to minimize potential conflicts of interest which may arise
from multiple affiliations, the undersigned agrees to present to the Company for
its consideration, prior to presentation to any other person or entity, any
suitable opportunity to acquire an operating business in the healthcare
industry, until the earlier of the consummation by the Company of a Business
Combination, the liquidation of the Company, subject to any pre-existing
fiduciary obligations the undersigned might have.

<PAGE>

      4. The undersigned acknowledges and agrees that the Company will not
consummate any Business Combination that involves a company which is affiliated
with any of the Insiders unless the Company obtains an opinion from an
independent investment banking firm reasonably acceptable to the Underwriter
that the Business Combination is fair to the Company's stockholders from a
financial perspective.

      5. Neither the undersigned, any member of the family of the undersigned,
nor any affiliate ("Affiliate") of the undersigned will be entitled to receive
and will not accept any compensation for services rendered to the Company prior
to the consummation of the Business Combination; provided that, commencing on
the Effective Date, Confluence Acquisition, LLC, a limited liability company
("Related Party"), shall be allowed to charge the Company an allocable share of
Related Party's overhead, up to $7,500 per month, to compensate it for the
Company's use of Related Party's offices, utilities and personnel. Related Party
shall also be entitled to reimbursement from the Company for their out-of-pocket
expenses incurred in connection with seeking and consummating a Business
Combination.

      6. Neither the undersigned, any member of the family of the undersigned,
nor any Affiliate of the undersigned will be entitled to receive or accept a
finder's fee or any other compensation in the event the undersigned, any member
of the family of the undersigned or any Affiliate of the undersigned originates
a Business Combination.

      7. The undersigned will escrow his Insider Shares for the three year
period commencing on the Effective Date subject to the terms of a Stock Escrow
Agreement which the Company will enter into with the undersigned and Continental
Stock Transfer & Trust Company as escrow agent.

      8. The undersigned agrees that, during the period terminating on the third
anniversary of the Effective Date, he will not become involved (whether as
owner, manager, operator, creditor, partner, shareholder, joint venturer,
member, employee, officer, director, consultant or otherwise) with any
Acquisition Fund (as defined in Section 13(i) below), unless such Acquisition
Fund engages the Underwriter to be the managing underwriter of the initial
public offering of the Acquisition Fund's securities.

      The undersigned hereby agrees and acknowledges that (i) the Underwriter
would be irreparably injured in the event of a breach by the undersigned of any
of his obligations under this paragraph 8, (ii) monetary damages would not be an
adequate remedy for any such breach, and (iii) the Underwriter shall be entitled
to injunctive relief, in addition to any other remedy they may have, in the
event of such breach.

      9. The undersigned represents and warrants that:

            (a) it is not subject to or a respondent in any legal action for,
any injunction, cease-and-desist order or order or stipulation to desist or
refrain from any act or practice relating to the offering of securities in any
jurisdiction;

            (b) it has never been convicted of or pleaded guilty to any crime
(i) involving any fraud or (ii) relating to any financial transaction or
handling of funds of

                                       6
<PAGE>

another person, or (iii) pertaining to any dealings in any securities and it is
not currently a defendant in any such criminal proceeding; and

            (c) it has never been suspended or expelled from membership in any
securities or commodities exchange or association or had a securities or
commodities license or registration denied, suspended or revoked.

      10. The undersigned has full right and power, without violating any
agreement by which it is bound, to enter into this letter agreement.

      11. The undersigned authorizes any employer, financial institution, or
consumer credit reporting agency to release to the Underwriter and its legal
representatives or agents (including any investigative search firm retained by
the Underwriter) any information they may have about my background and finances
(the "Information"). Neither the Underwriter nor its agents shall be violating
the undersigned's right of privacy in any manner in requesting and obtaining the
Information and the undersigned hereby releases them from liability for any
damage whatsoever in that connection.

      12. This letter agreement shall be governed by and construed and enforced
in accordance with the laws of the State of Delaware, without giving effect to
conflicts of laws principles that would result in the application of the
substantive laws of another jurisdiction.

      13. As used herein,

                  (i) "Acquisition Fund" shall mean any company formed with the
intent to offer securities to the public and use the proceeds to consummate one
or more Business Combinations which are unspecified at the time of the
securities offering.

                  (ii) "Business Combination" shall mean an acquisition by
merger, capital stock exchange, asset or stock acquisition, reorganization or
otherwise, of an operating business selected by the Company;

                  (iii) "Insiders" shall mean all officers, directors and
stockholders of the Company immediately prior to the IPO;

                  (iv) "Insider Shares" shall mean all of the shares of Common
Stock of the Company owned by an Insider prior to the IPO;

                  (v) "IPO Shares" shall mean the shares of Common Stock issued
in the Company's IPO; and

                  (vi) "Questionnaire" means that Questionnaire for Officers and
Directors executed by the undersigned together with any supplement or amendment
thereto.

                                                  _________________________

                                       7
<PAGE>

                                                  (form for entity stockholders)

                                ____________ 2005

Confluence Acquisition Partners I, Inc.
12444 Powerscourt Drive
Suite 225
St. Louis, Missouri 63131

Dawson James Securities, Inc.
925 South Federal Highway, 6th Floor
Boca Raton, FL 33432

Re: Initial Public Offering

Gentlemen:

      The undersigned stockholder of Confluence Acquisition Partners I, Inc.
(the "Company"), in consideration of Dawson James Securities, Inc. (the
"Underwriter") entering into a letter of intent (the "Letter of Intent") to
underwrite an initial public offering of the securities of the Company ("IPO")
and embarking on the IPO process, hereby agrees as follows (certain capitalized
terms used herein are defined in paragraph 13 hereof):

      1. If the Company solicits approval of its stockholders of a Business
Combination, the undersigned will vote all Insider Shares owned by it in
accordance with the majority of the votes cast by the holders of the IPO Shares.

      2. In the event that the Company fails to consummate a Business
Combination within 18 months from the effective date (the "Effective Date") of
the registration statement (the "Registration Statement") relating to the IPO
(or 24 months under the circumstances described in the prospectus relating to
the IPO), the undersigned will (i) cause the Trust Fund (as defined in the
Registration Statement") to be liquidated and distributed to the holders of IPO
Shares and (ii) take all reasonable actions within its power to cause the
Company to liquidate as soon as reasonably practicable. The undersigned waives
any and all right, title, interest or claim of any kind in or to any
distribution of the Trust Fund and any remaining net assets of the Company it
may have to receive any distribution of cash, property or other assets as a
result of such liquidation with respect to its Insider Shares ("Claim") and
hereby waives any Claim the undersigned may have in the future as a result of,
or arising out of, any contracts or agreements with the Company and will not
seek recourse against the Trust Fund for any reason whatsoever.

      3. The undersigned acknowledges and agrees that the Company will not
consummate any Business Combination that involves a company which is affiliated
with

<PAGE>

any of the Insiders unless the Company obtains an opinion from an independent
investment banking firm reasonably acceptable to the Underwriter that the
Business Combination is fair to the Company's stockholders from a financial
perspective.

      4. Neither the undersigned, any member of the family of the undersigned,
nor any affiliate ("Affiliate") of the undersigned will be entitled to receive
and will not accept any compensation for services rendered to the Company prior
to the consummation of the Business Combination; provided that, commencing on
the Effective Date, Confluence Acquisition, LLC, a limited liability company
("Related Party"), shall be allowed to charge the Company an allocable share of
Related Party's overhead, up to $7,500 per month, to compensate it for the
Company's use of Related Party's offices, utilities and personnel. Related Party
shall also be entitled to reimbursement from the Company for their out-of-pocket
expenses incurred in connection with seeking and consummating a Business
Combination.

      5. Neither the undersigned, any member of the family of the undersigned,
nor any Affiliate of the undersigned will be entitled to receive or accept a
finder's fee or any other compensation in the event the undersigned, any member
of the family of the undersigned or any Affiliate of the undersigned originates
a Business Combination.

      6. The undersigned will escrow its Insider Shares for the three year
period commencing on the Effective Date subject to the terms of a Stock Escrow
Agreement which the Company will enter into with the undersigned and Continental
Stock Transfer & Trust Company as escrow agent.

      7. The undersigned agrees that, during the period terminating on the third
anniversary of the Effective Date, he will not become involved (whether as
owner, manager, operator, creditor, partner, shareholder, joint venturer,
member, employee, officer, director, consultant or otherwise) with any
Acquisition Fund (as defined in Section 12(i) below), unless such Acquisition
Fund engages the Underwriter to be the managing underwriter of the initial
public offering of the Acquisition Fund's securities.

      The undersigned hereby agrees and acknowledges that (i) the Underwriter
would be irreparably injured in the event of a breach by the undersigned of any
of his obligations under this paragraph 8, (ii) monetary damages would not be an
adequate remedy for any such breach, and (iii) the Underwriter shall be entitled
to injunctive relief, in addition to any other remedy they may have, in the
event of such breach.

      8. The undersigned represents and warrants that:

            (a) he is not subject to or a respondent in any legal action for,
any injunction, cease-and-desist order or order or stipulation to desist or
refrain from any act or practice relating to the offering of securities in any
jurisdiction;

            (b) he has never been convicted of or pleaded guilty to any crime
(i) involving any fraud or (ii) relating to any financial transaction or
handling of funds of another person, or (iii) pertaining to any dealings in any
securities and he is not currently a defendant in any such criminal proceeding;
and

                                       9
<PAGE>

            (c) he has never been suspended or expelled from membership in any
securities or commodities exchange or association or had a securities or
commodities license or registration denied, suspended or revoked.

      9. The undersigned has full right and power, without violating any
agreement by which he is bound, to enter into this letter agreement.

      10. The undersigned authorizes any employer, financial institution, or
consumer credit reporting agency to release to the Underwriter and its legal
representatives or agents (including any investigative search firm retained by
the Underwriter) any information they may have about my background and finances
(the "Information"). Neither the Underwriter nor its agents shall be violating
the undersigned's right of privacy in any manner in requesting and obtaining the
Information and the undersigned hereby releases them from liability for any
damage whatsoever in that connection.

      11. This letter agreement shall be governed by and construed and enforced
in accordance with the laws of the State of Delaware, without giving effect to
conflicts of laws principles that would result in the application of the
substantive laws of another jurisdiction.

      12. As used herein,

                  (i) "Acquisition Fund" shall mean any company formed with the
intent to offer securities to the public and use the proceeds to consummate one
or more Business Combinations which are unspecified at the time of the
securities offering.

                  (ii) "Business Combination" shall mean an acquisition by
merger, capital stock exchange, asset or stock acquisition, reorganization or
otherwise, of an operating business selected by the Company;

                  (iii) "Insiders" shall mean all officers, directors and
stockholders of the Company immediately prior to the IPO;

                  (iv) "Insider Shares" shall mean all of the shares of Common
Stock of the Company owned by an Insider prior to the IPO;

                  (v) "IPO Shares" shall mean the shares of Common Stock issued
in the Company's IPO; and

                  (vi) "Questionnaire" means that Questionnaire for Officers and
Directors executed by the undersigned together with any supplement or amendment
thereto.

                                                  _________________________

                                       10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]